Skip to content

Correlation Study of Serum Adiponectin and Cerebrospinal Fluid Neurofilament Light Chain Protein in Elderly Patients Undergoing Lower Extremity Surgery with Perioperative Neurocognitive Disorders

Correlation Study of Serum Adiponectin and Cerebrospinal Fluid Neurofilament Light Chain Protein in Elderly Patients Undergoing Lower Extremity Surgery with Perioperative Neurocognitive Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095112
Enrollment
Unknown
Registered
2025-01-02
Start date
2025-01-03
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative Neurocognitive Disorder.

Interventions

Sponsors

Dongguan People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Have a full understanding of the purpose and significance of this trial, voluntarily participate in this clinical trial, and have signed the informed consent form; 2. American Society of Anesthesiologists (ASA) grade I-III; 3. Patients who undergo elective lower limb surgery and need to undergo combined spinal-epidural anesthesia; 4. Age 60 and above (including 60 years old), gender is not limited; 5. Preoperative MMSE score for illiterate > 17 points, 20 points for primary school >, and 24 points for middle school or above>; 6. No sedative drugs, antidepressants or other drugs that may interfere with the central nervous system in the past 2 years; 7. No history of central nervous system or psychiatric and psychological diseases.

Exclusion criteria

Exclusion criteria: 1. Presence of contraindications to neuraxial anesthesia; 2. Severe systemic diseases (such as malignant tumors) that may affect the level of PND biomarkers in cerebrospinal fluid; 3. Long-term use of psychotropic drugs, steroid drugs, hormones; 4. Patients with a history of cognitive dysfunction in the past, and central nervous system diseases such as multiple sclerosis and neuromyelitis optica.

Design outcomes

Primary

MeasureTime frame
Serum adiponectin ;Cerebrospinal fluid neurofilament light chain protein;Preoperative and postoperative MMSE scores;

Countries

China

Contacts

Public ContactXiaohong Chen

Dongguan People's Hospital,

13929200305@139.com+86 136 0026 3882

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026